Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.000
-0.100-0.90%
Volume:2.42M
Turnover:26.71M
Market Cap:28.25B
PE:17.46
High:11.100
Open:11.180
Low:10.960
Close:11.100
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:0.60
T/O Rate:0.09%
Dividend:0.21
Dividend Rate:1.91%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.57
PE(LYR):17.46
PS:2.78

Loading ...

Simcere files HKEX return disclosing share repurchase at HKD 11.19 each

Reuters
·
May 18

SIMCERE PHARMA Executes Share Buyback on May 14

Stock News
·
May 15

SIMCERE PHARMA (02096) Spends HK$12.30 Million on Share Buyback

Stock News
·
May 13

Simcere files HKEX next-day return, discloses share repurchase at HKD 11.57 each

Reuters
·
May 13

Simcere Pharmaceutical Group's (HKG:2096) Solid Profits Have Weak Fundamentals

Simply Wall St.
·
May 08

Simcere Pharma Keeps Share Capital Unchanged in April 2026, Public Float Remains Compliant

Bulletin Express
·
May 06

Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug

MT Newswires Live
·
May 06

BRIEF-Simcere Pharmaceutical Receives NMPA China Clinical Trial Approval For SIM0613

Reuters
·
May 06

Simcere Pharma receives NMPA approval to begin clinical trial of LRRC15 ADC SIM0613; partnership with Ipsen worth up to US$1.06 billion progresses

Bulletin Express
·
May 06

SIMCERE PHARMA's ADC Candidate SIM0613 Receives Chinese Regulatory Nod for Clinical Trials

Stock News
·
May 06

Simcere Pharmaceutical - Receives China Clinical Trial Approval From Nmpa for Sim0613 in Advanced Solid Tumors

THOMSON REUTERS
·
May 06

Simcere Pharma buys back 1.38 million shares on 5 May; cumulative 2026 repurchases reach 15.05 million

Bulletin Express
·
May 05

Simcere Pharma Adds 847,000-Share Buyback; Cumulative Repurchases Reach 13.67 Million

Bulletin Express
·
May 04

SIMCERE PHARMA Spends HK$10 Million on Share Buyback

Stock News
·
May 04

Simcere files HKEX next-day disclosure return, reports share buyback at HKD 11.91

Reuters
·
May 04

SIMCERE PHARMA's New Drug Application for Ledokibai Monoclonal Antibody Accepted by Regulators

Stock News
·
Apr 30

Simcere says China regulator accepts NDA for atopic dermatitis drug rademikibart

Reuters
·
Apr 30

BRIEF-Simcere Pharmaceutical Says NDA For Rademikibart Accepted By NMPA

Reuters
·
Apr 30

Simcere Pharmaceutical - Nda for Rademikibart Accepted by Nmpa on April 29, 2026

THOMSON REUTERS
·
Apr 30

Simcere Pharmaceutical's Profit Jumps 86% in 2025

MT Newswires Live
·
Apr 29